Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
VBI Vaccines Inc/BC (VBIV)
Sector: Healthcare; Industry: Biotechnology

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology in Israel, the United States, and internationally. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for a functional cure of chronic hepatitis B. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the target virus to elicit a potent immune response. It primarily serves physicians and pharmacists through direct sales. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2018-12-17 Kariv Tomer Director Buy 1,428,571 $1.40 $1,999,999 No

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.